Transcutaneous Electrical Stimulation for Stroke Patients
Launched by SHIRLEY RYAN ABILITYLAB · Apr 25, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called transcutaneous electrical stimulation of the spinal cord (TESS) to see how it can help people who have difficulty using one arm after a stroke, a condition known as upper limb hemiparesis. The study will compare two groups: one group will receive TESS along with special training for their affected arm, while the other group will receive the same training but with a fake version of TESS. The goal is to understand if TESS can improve recovery for stroke patients.
To be eligible for this trial, participants should be at least 18 years old, have had a stroke at least six months prior, and have some difficulty using their affected arm, as shown by a specific assessment. They should also be able to understand and follow study instructions and not be receiving regular occupational therapy. Participants will need to get approval from their doctor to join. If you or a family member are interested, please note that the study is currently recruiting and is open to all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • able and willing to give written consent and comply with study procedures
- • at least 6 months post-stroke
- • hemiplegia secondary to stroke
- • UE Fugle Meyer Assessment \<35
- • not currently receiving regular occupational therapy services
- • participant has received clearance from physician to participate in study
- • participant has at least a rudimentary comprehension of English
- Exclusion Criteria:
- • botox injection in upper extremity within the last 4 months
- • modified ashworth score of 4 in any joint of the affected limb
- • pregnant or nursing
- • using a powered, implanted cardiac device for monitoring or support of heart function (i.e. pacemaker, defibrillator, or LVAD), or anti-spasticity implantable pumps, or cochlear implants
- • unhealed bone fractures
- • severe contractures in the upper extremities
- • active cancer or cancer remission less than 5 years
- • orthopedic dysfunction, injury, or surgery that would impact the individual's ability to use the upper extremities
- • recent procedure or operation of the spinal cord within the past year
- • traumatic brain injury or neurological conditions that would impact the study
- • skull fracture that has developed within the past 6 months
- • non-English speakers
About Shirley Ryan Abilitylab
Shirley Ryan AbilityLab is a leading research and rehabilitation institute dedicated to advancing the science of physical medicine and rehabilitation. Based in Chicago, Illinois, the organization integrates clinical care, research, and education to enhance the quality of life for individuals with disabilities and chronic conditions. Known for its innovative approach, Shirley Ryan AbilityLab conducts clinical trials that aim to develop and evaluate cutting-edge therapies and technologies, fostering a collaborative environment that bridges the gap between laboratory research and patient care. Through its commitment to excellence, the institute strives to empower patients and improve outcomes in rehabilitation medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported